|
Opening Ceremony |
|
Plenary Session 1: Welcome & Introductory Talks |
|
Plenary Session 2: Epidemiology, Prevention and Natural History of Hepatitis |
|
Parallel Session 1: Innate Immune Responses to HBV and HCV Infection |
|
Parallel Session 2: Viral Replication and Host Cell Interactions |
|
Parallel Session 3: Geographical Diversity and Epidemiology |
|
Parallel Session 4: Outcome of Viral Hepatitis Prevention and Treatment |
|
Parallel Session 5: Noninvasive Markers of Liver Fibrosis |
|
Plenary Session 3: Molecular and Cellular Virology |
|
Parallel Session 6: Acquired Immune Responses to HBV and HCV Infection |
|
Parallel Session 7: Viral Evolution and Genotype Distribution |
|
Parallel Session 8: Natural History of Hepatitis and Co-infections |
|
Parallel Session 9: Combination Therapy of Viral Hepatitis |
|
Parallel Session 10: Management of acute Liver Failure |
|
Plenary Session 4:Immunology and Vaccine Development |
|
Parallel Session 11: Mutants and Implications |
|
Parallel Session 12: Pathogenesis and Viral Kinetics |
|
Parallel Session 13: Preventive Vaccines and Therapeutic Vaccines |
|
Parallel Session 14: Innovative Therapeutic Approaches |
|
Parallel Session 15: Early Detection and Management of HCC |
|
Plenary Session 5: Diagnosis and Treatment of Hepatitis B and C |
|
Parallel Session 16: Autoimmune Hepatitis |
|
Parallel Session 17: Viral Resistance |
|
Parallel Session 18: Strategies for Viral Hepatitis Vaccination |
|
Parallel Session 19: Novel Markers for Diagnosis and Individualized Treatment |
|
Parallel Session 20: Molecular and genomic progress of HCC |
|
Plenary Session 6: Liver Diseases and Hepatocellular Carcinoma |
|
Parallel Session 21: Transversal Integration of Basic Science |
|
Parallel Session 22: Host Genetics and Pharmacogenomics for HCV and HBV |
|
Parallel Session 23: Animal and Cellular Models |
|
Parallel Session 24: Extrahepatic Manifestations of Hepatitis B and C |
|
Parallel Session 25: Liver Transplantation |
|
Plenary Session 7: Future Directions
|